Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.

Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M.

J Am Vet Med Assoc. 2008 May 15;232(10):1496-503. doi: 10.2460/javma.232.10.1496.

PMID:
18479239
2.

Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.

Oyama MA, Rush JE, Rozanski EA, Fox PR, Reynolds CA, Gordon SG, Bulmer BJ, Lefbom BK, Brown BA, Lehmkuhl LB, Prosek R, Lesser MB, Kraus MS, Bossbaly MJ, Rapoport GS, Boileau JS.

J Am Vet Med Assoc. 2009 Dec 1;235(11):1319-25. doi: 10.2460/javma.235.11.1319.

PMID:
19951101
3.
4.

Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.

Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA.

J Vet Cardiol. 2009 May;11 Suppl 1:S81-6. doi: 10.1016/j.jvc.2009.02.001.

PMID:
19394913
5.

The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.

Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S.

J Small Anim Pract. 2008 Jan;49(1):26-32.

PMID:
18005104
6.

Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.

Ettinger SJ, Farace G, Forney SD, Frye M, Beardow A.

J Am Vet Med Assoc. 2012 Jan 15;240(2):171-80. doi: 10.2460/javma.240.2.171.

PMID:
22217025
7.

Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission.

Serres F, Pouchelon JL, Poujol L, Lefebvre HP, Trumel C, Daste T, Sampedrano CC, Gouni V, Tissier R, Hawa G, Chetboul V.

J Vet Cardiol. 2009 Dec;11(2):103-21. doi: 10.1016/j.jvc.2009.07.001.

PMID:
19850546
8.

Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.

Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.

J Vet Cardiol. 2009 May;11 Suppl 1:S51-61. doi: 10.1016/j.jvc.2008.12.001.

PMID:
19394287
9.

Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort study.

Kirchhoff C, Leidel BA, Kirchhoff S, Braunstein V, Bogner V, Kreimeier U, Mutschler W, Biberthaler P.

Crit Care. 2008;12(5):R118. doi: 10.1186/cc7013.

10.

Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.

Connolly DJ, Soares Magalhaes RJ, Fuentes VL, Boswood A, Cole G, Boag A, Syme HM.

J Vet Cardiol. 2009 May;11 Suppl 1:S41-50. doi: 10.1016/j.jvc.2009.03.001.

PMID:
19394286
11.
12.

Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.

Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.

J Vet Intern Med. 2015 Jan;29(1):171-9. doi: 10.1111/jvim.12472.

13.

Clinical implications of measurement of plasma atrial natriuretic peptide concentration in dogs with spontaneous heart disease.

Hori Y, Yamano S, Kanai K, Hoshi F, Itoh N, Higuchi S.

J Am Vet Med Assoc. 2011 Oct 15;239(8):1077-83. doi: 10.2460/javma.239.8.1077.

PMID:
21985348
14.

The use of NT-proBNP assay in the management of canine patients with heart disease.

Oyama MA, Singletary GE.

Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):545-58. doi: 10.1016/j.cvsm.2010.03.004. Review.

PMID:
20610010
15.

Cardiac troponin I: evaluation I of a biomarker for the diagnosis of heart disease in the dog.

Spratt DP, Mellanby RJ, Drury N, Archer J.

J Small Anim Pract. 2005 Mar;46(3):139-45.

PMID:
15789809
16.

The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.

Wolf J, Gerlach N, Weber K, Klima A, Wess G.

Vet Clin Pathol. 2013 Jun;42(2):196-206. doi: 10.1111/vcp.12044.

PMID:
23614733
17.

Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.

Lalor SM, Connolly DJ, Elliott J, Syme HM.

J Vet Cardiol. 2009 May;11 Suppl 1:S71-9. doi: 10.1016/j.jvc.2009.01.004.

PMID:
19398225
18.

Effects of sample handling on serum N-terminal proB-type natriuretic peptide concentration in normal dogs and dogs with heart disease.

Collins SA, Patteson MW, Connolly DJ, Brodbelt DC, Torrance AG, Harris JD.

J Vet Cardiol. 2010 Apr;12(1):41-8. doi: 10.1016/j.jvc.2010.01.001.

PMID:
20226751
19.

N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.

Moonarmart W, Boswood A, Luis Fuentes V, Brodbelt D, Souttar K, Elliott J.

J Small Anim Pract. 2010 Feb;51(2):84-96. doi: 10.1111/j.1748-5827.2009.00889.x.

PMID:
20070494
Items per page

Supplemental Content

Support Center